Data on 90-day episode of care outcomes, collected using the Comprehensive Care for Joint Replacement model, suggest that if Smith & Nephew’s OXINIUM™ Oxidized Zirconium alloy bearing surface was used in all U.S. primary hip procedures in 2020 (projected volume to be 498,000), it could yield ~$296MM in savings to the U.S. health system.
The data compared outcomes for OXINIUM to all other non-OXINIUM bearing surfaces for total hip replacement. Key takeaways included:
OXINIUM reduced post-acute average cost per 90-day episode of care by $595 as a result of lower use of Skilled Nursing Facilities, fewer related hospital readmissions and less time in inpatient rehab
Compared to patients implanted with other bearing surfaces, those implanted with OXINIUM demonstrated:
12.7% lower rates of 90-day all cause readmissions
15.9% lower rates of discharge to skilled nursing facilities
11.9% lower average length of stay in SNFs1, and
34.4% lower revision rate in the first 90 days
OXINIUM femoral heads launched in 2002 and have been implanted over 700,000 times worldwide, to date.
Data on 90-day episode of care outcomes, collected using the Comprehensive Care for Joint Replacement model, suggest that if Smith & Nephew's OXINIUM™ Oxidized Zirconium alloy bearing surface was used in all U.S. primary hip procedures in 2020 (projected volume to be 498,000), it could yield ~$296MM in savings to the U.S. health system. ...
Data on 90-day episode of care outcomes, collected using the Comprehensive Care for Joint Replacement model, suggest that if Smith & Nephew’s OXINIUM™ Oxidized Zirconium alloy bearing surface was used in all U.S. primary hip procedures in 2020 (projected volume to be 498,000), it could yield ~$296MM in savings to the U.S. health system.
The data compared outcomes for OXINIUM to all other non-OXINIUM bearing surfaces for total hip replacement. Key takeaways included:
OXINIUM reduced post-acute average cost per 90-day episode of care by $595 as a result of lower use of Skilled Nursing Facilities, fewer related hospital readmissions and less time in inpatient rehab
Compared to patients implanted with other bearing surfaces, those implanted with OXINIUM demonstrated:
12.7% lower rates of 90-day all cause readmissions
15.9% lower rates of discharge to skilled nursing facilities
11.9% lower average length of stay in SNFs1, and
34.4% lower revision rate in the first 90 days
OXINIUM femoral heads launched in 2002 and have been implanted over 700,000 times worldwide, to date.
Copy to clipboard 
